Myeloperoxidase (MPO) is a member of the superfamily of heme peroxidases that is mainly
expressed in neutrophils and monocytes. MPO-derived reactive species play a key role in …

Atherosclerosis is the main pathophysiological process underlying coronary artery disease
(CAD). Acute complications of atherosclerosis, such as myocardial infarction, are caused by …

While the received traditional predictors are still the mainstay in the diagnosis and prognosis
of CVD events, increasing studies have focused on exploring the ancillary effect of …

Objectives: We investigated whether markers of platelet, neutrophil and endothelial
activation, plasma fibrin clot properties and patient clinical profile may characterize coronary …

Coronary artery disease (CAD) and myocardial infarction (MI) remain leading causes of
death and disability worldwide. CAD begins with the formation of atherosclerotic plaques …

Coronary artery disease (CAD), acute coronary syndrome (ACS), and heart failure (HF) are
major global health issues with high morbidity and mortality rates. Biomarkers like cardiac …

Background: Myeloperoxidase (MPO) is an enzyme, elevated in the atheroma and serum of
a patient with atherosclerotic vessels. The aim of this study is to investigate whether the …

Background and Objectives: The process of atherosclerotic plaque formation and its
destabilisation is a process in which many proteins and cytokines are involved. Examples of …

Acute coronary syndrome (ACS) is the main cause of mortality for coronary artery disease
(CAD). Accordingly, earlier detection and diagnosis might be a key point for reducing the …

The destabilization of atherosclerotic plaque and resultant cardiovascular events remain the
leading cause of morbidity and mortality worldwide, 1 with acute myocardial infarction (AMI) …